Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 3Biliary Tract Neoplasms 3Neoplasms 2Stomach Neoplasms 1Pancreatic Cancer Resectable 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Locally Advanced Pancreatic Adenocarcinoma 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Breast Cancer Organoids 1Brain Neoplasms 1

Interventions

folfirinox 1Leucovorin 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Locally Advanced Pancreatic Adenocarcinoma × Gemcitabine × Clear all
NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Oslo University Hospital

Active not recruiting
251 enrolled
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡